Impilo invests in Decon – a leading mobility player within power-assisted electrical wheelchair solutions
Impilo has acquired a majority position in Decon Wheel AB (“Decon”), a developer and producer of high-quality power assist electrical solutions for manual wheelchairs, from its founders, who will continue as minority owners. In parallel with Impilo’s investment into Decon, Decon will acquire its long-term partner, Mobility Products, in the Netherlands.
Decon was founded in 1989 in Hyltebruk, Sweden, and employs c. 40 employees with 2022 sales of SEK 124m. Decon develops, assemblies, and distributes high-quality power-assisted electrical solutions for wheelchairs. With a user-centric development process, Decon’s solutions enable an active life for people with disabilities and thus “create freedom” in their day-to-day life. The company has its assembly facility in Hyltebruk, and from there, they serve a distributor network across +25 countries.
Read moreNews
Impilo’s portfolio company Decon acquires Acekare – a French-based manufacturer and distributor of mobility assistance solutions
The acquisition of Acekare marks an important step in Decon’s strategic ambition to build a leading European niche mobility platform by adding a complementary product company to its existing offering and establishing a direct presence in the French market
Impilo’s portfolio company Pelago Bioscience acquires RG Discovery, forming an integrated drug discovery partner spanning biology and chemistry
Impilo’s portfolio company Pelago Bioscience acquires RG Discovery, forming an integrated drug discovery partner spanning biology and chemistry
Impilo completes the acquisition of Oticon Medical
We are pleased to announce that Impilo has today completed the acquisition of Oticon Medical from Demant A/S. This marks the first investment in our recently raised Fund II.